Non-alcoholic fatty liver disease (NAFLD) is a public health burden. Steatosis as the “first hit”, and oxidative stress, inflammation, mitochondrial dysfunction, and endoplasmic reticulum stress as the “second hits” are the main contributors of the progression of fatty liver to non-alcoholic steatohepatitis (NASH). Dietary polyphenols have shown promise in protecting the liver against NAFLD. The relative effectiveness and mechanisms of different polyphenols however is mostly unknown. In this thesis HepG2 hepatocytes exposed to oleic or palmitic acid were used as a model system to explore the ability of selected polyphenols (resveratrol, quercetin, catechin, cyanidin, cyanidin-3-glucoside, berberine) from different classes to protect agains...
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide and is a leading...
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple factors, which...
Metabolic syndrome (MetS) is a chronic disease, including abdominal obesity, dyslipidemia, hyperglyc...
Non-alcoholic fatty liver disease (NAFLD) is a public health burden. Steatosis as the “first hit”, a...
In this study, we aimed to determine the relative effectiveness of common dietary polyphenols or the...
Non-alcoholic fatty liver disease (NAFLD) is a common clinicopathological condition, encompassing a ...
Non-alcoholic fatty liver disease (NAFLD), the most predominant liver disease worldwide, is a progre...
Abstract: Current food tendencies, suboptimal dietary habits and a sedentary lifestyle are spreadin...
Non-alcoholic fatty liver disease (NAFLD) represents the most common chronic liver disease in indust...
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple factors, which...
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple factors, which...
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple factors, which...
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple factors, which...
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple factors, which...
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple factors, which...
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide and is a leading...
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple factors, which...
Metabolic syndrome (MetS) is a chronic disease, including abdominal obesity, dyslipidemia, hyperglyc...
Non-alcoholic fatty liver disease (NAFLD) is a public health burden. Steatosis as the “first hit”, a...
In this study, we aimed to determine the relative effectiveness of common dietary polyphenols or the...
Non-alcoholic fatty liver disease (NAFLD) is a common clinicopathological condition, encompassing a ...
Non-alcoholic fatty liver disease (NAFLD), the most predominant liver disease worldwide, is a progre...
Abstract: Current food tendencies, suboptimal dietary habits and a sedentary lifestyle are spreadin...
Non-alcoholic fatty liver disease (NAFLD) represents the most common chronic liver disease in indust...
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple factors, which...
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple factors, which...
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple factors, which...
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple factors, which...
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple factors, which...
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple factors, which...
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide and is a leading...
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple factors, which...
Metabolic syndrome (MetS) is a chronic disease, including abdominal obesity, dyslipidemia, hyperglyc...